Transgene (XPAR:TNG) Buildings And Improvements : €3.24 Mil (As of Dec. 2023)

View and export this data going back to 1998. Start your Free Trial

What is Transgene Buildings And Improvements?

Transgene's quarterly buildings and improvements increased from Dec. 2022 (€2.68 Mil) to Jun. 2023 (€17.84 Mil) but then declined from Jun. 2023 (€17.84 Mil) to Dec. 2023 (€3.24 Mil).

Transgene's annual buildings and improvements declined from Dec. 2021 (€17.47 Mil) to Dec. 2022 (€2.68 Mil) but then increased from Dec. 2022 (€2.68 Mil) to Dec. 2023 (€3.24 Mil).

Transgene Buildings And Improvements Historical Data

The historical data trend for Transgene's Buildings And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Transgene Buildings And Improvements Chart

Transgene Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Buildings And Improvements

Get a 7-Day Free Trial

16.39

17.29

17.47

2.68

3.24

Transgene Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Buildings And Improvements	Get a 7-Day Free Trial															17.47	17.52	2.68	17.84	3.24

Transgene Buildings And Improvements Calculation

Buildings are typically valued at the time of acquisition or construction. Broker and architect fees, permits, etc. can be covered within this category. Building components, such as a roof, are normally recorded separately in an asset register since the value and useful lives of these components equal much less than the building itself.

Building improvements that extend the useful life of a building will fall into the category of “building improvements” and should be capitalized. Improvements are commonly recorded at acquisition cost. Building improvement examples include roofing, remodeling, replacements, etc.

Transgene (XPAR:TNG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Transgene SA (XPAR:TNG) » Definitions » Buildings And Improvements

Comparable Companies

Traded in Other Exchanges

TGNA:Germany

Address

400 Boulevard Gonthier d’Andernach, Parc d’Innovation - CS80166, Illkirch-Graffenstaden, FRA, 67400

Website

https://www.transgene.fr

Transgene SA is a biotechnology company. It is involved in the business of discovering and focusing immune-targeted therapies for the treatment of cancer and infectious diseases. The company's clinical-stage programs are TG4010 for non-small cell lung cancer and Pexa-vec for liver cancer. Its product pipeline includes TG4001, TG1050, TG6002 etc. It is engaged in clinical research and development of therapeutic vaccines and immunotherapeutic products.

Transgene (XPAR:TNG) Headlines

No Headlines